Medical researchers have discovered that a genetic mutation may be responsible for why some people who test positive for COVID-19 do not develop symptoms, while the disease proves to range between mildly debilitating and downright lethal to others. This mutation, one responsible for regulation of the immune system, appears toread more
The new UK coronavirus strain may be 30 to 40 percent more deadly than the original SARS-CoV-2 variant, according to a UK governmental health advisory group, despite initial hopes that the faster-spreading variant of the coronavirus had no greater impact on hospitalizations or death than its predecessor. This new developmentread more
As tenacious and pervasive as the coronavirus at the root of our long-running pandemic appears to be, SARS-CoV-2 has not only a host of strengths aiding its spread, but it also hides numerous vulnerabilities that could be exploited to help contain and defeat the deadly pathogen. Aside from lastingread more
Three SARS-CoV-2 vaccines have now been fast tracked for development by the FDA. The Oxford group, CanSino Biologics and now also Moderna Pharmaceuticals have all had their experimental vaccines approved to move into Phase II trials. This means that they will begin enrolling subject participants in the coming weeks. Thisread more